跳到正文
原文
Endpoints News 生物医药· Lei Lei Wu·· 2026-10-07AI 评分50

MimiVax的胶质母细胞瘤癌症疫苗未达IIb期主要目标

MimiVax's cancer vaccine for glioblastoma narrowly misses Phase 2b goal

AI 导读

MimiVax的胶质母细胞瘤癌症疫苗在IIb期研究中未能达到主要目标,该研究历时十余年。原文指出该结果令人失望,但研究团队表示后续仍有方向可探讨。

正文

A brain can­cer ef­fort more than a decade in the mak­ing has cul­mi­nat­ed in a dis­ap­point­ing study re­sult — but re­searchers be­hind it are con­tend­ing there’s …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

来源:Endpoints News 生物医药 · endpoints.news